Ms. Nadia Miriam Underwood Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 901 Moraga Rd Ste D, Lafayette, CA 94549 Phone: 510-689-2700 |
Lori Cs Belhumeur, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 409 Read Dr, Lafayette, CA 94549 Phone: 925-385-0530 |
Maureen Wallace, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 919 Village Center, Ste 7, Lafayette, CA 94549 Phone: 925-283-2610 |
Angela Ristow, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 901 Moraga Rd, Lafayette, CA 94549 Phone: 415-322-0965 |
Avi Daneal Levin, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 3366 Mt Diablo Blvd Apt 205, Lafayette, CA 94549 Phone: 773-318-3284 |
Ashley Henderson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3746 Mt Diablo Blvd Ste 201e, Lafayette, CA 94549 Phone: 510-435-0007 |
Sharlene Ann Simpson Foox, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1658 Glen Oak Ct, Lafayette, CA 94549 Phone: 925-354-0725 |
Peggie Lee, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3433 Golden Gate Way Ste A, Lafayette, CA 94549 Phone: 925-385-3110 |
News Archive
A medical imaging procedure known as lung scintigraphy may be more reliable than pulmonary CT angiography (CTA) for identifying or excluding pulmonary embolism (PE) in pregnant patients, according to a study published in the November issue of the American Journal of Roentgenology.
"The World Health Organization (WHO) established a global monitoring framework for non-communicable diseases (NCDs) at a Geneva meeting on November 9, 2012 - a little over a year after the U.N. General Assembly adopted a political declaration on NCDs," Management Sciences for Health's "Global Health Impact" blog reports, noting Ambassador Betty King, permanent representative of the U.S. to the U.N. and other international organizations in Geneva, announced the framework in November.
Nearly half of the world's population is at risk of infection by the dengue virus, yet there is no specific treatment for the disease. Now a therapy to protect people from the virus could finally be a step closer, thanks to a team at MIT.
RegeneRx Biopharmaceuticals, Inc. today announced its U.S. joint venture with G-treeBNT (ReGenTree LLC) has retained Ora, Inc. to conduct a phase 3 clinical trial for the orphan disorder, neurotrophic keratopathy (NK), and a 2b/3 dose-response, confirmatory trial for dry eye syndrome (DES) in the U.S. Both trials will be testing ReGenTree's preservative-free eye drops, RGN-259/GBT201, this year.
The relationship between a mother and her infant is believed by many to be the foundation of healthy childhood development, but researchers at the University of Missouri-Columbia have found pregnancy acceptance to be the first step in forming the mother/child bond.
› Verified 3 days ago